|
|
|
Corporate Profile: Cellmid
| Summary: |
Cellmid is focused on the research and development of therapeutics and diagnostics for heart attack, inflammatory diseases and cancer.
|
| Address (HQ): |
Suite 1802
Level 18
15 Castlereagh Street
Sydney, NSW 2000
Australia |
| Phone
#'s (HQ): |
| Main |
+61(0)2 9221 6830 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
+61(0)2 9221 8535 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
